This is in accordance with an immunohistochemical study among patients with triple-negative breast cancer, where a higher Nectin-4 expression was significantly associated with a lower T-stage and absence of lymph node metastases [43]. The gene discussed is NECTIN4; the disease is metastatic malignant neoplasm in the lymph nodes.